...
首页> 外文期刊>The journal of maternal-fetal & neonatal medicine >Proteomic analysis of cervical vaginal fluid proteins among women in recurrent preterm labor
【24h】

Proteomic analysis of cervical vaginal fluid proteins among women in recurrent preterm labor

机译:复发性早产妇女宫颈阴道液蛋白的蛋白质组学分析

获取原文
获取原文并翻译 | 示例

摘要

Objective: Proteomic analysis of four cervical-vaginal fluid (CVF) proteins to identify biomarkers of recurrent preterm birth (rPTB) in at-risk women prior to onset of preterm labor. Methods: Nested case control study from 2007 to 2011 of women with prior spontaneous preterm birth(s) (PTB) who underwent serial CVF sampling. Mass spectrometry analysis was used and ELISA analysis was performed to validate candidates. Results: 108 patients were enrolled and 10 cases and 20 gestational age matched controls were analyzed after exclusions. Of 748 CVF proteins identified, 72 had statistically significant (p<0.05) expression differences and 38 were highly differentially expressed (p<0.01). Four candidate proteins were abundant and involved in immune/inflammatory response, but ELISA analysis did not confirm altered expression patterns. Conclusion: The lack of confirmation of potential biomarkers identified by mass spectrometry and ELISA demonstrates the challenges of validating PTB biomarkers and suggests that a panel of biomarkers would improve the predictive value of CVF testing.
机译:目的:对四种宫颈阴道液(CVF)蛋白进行蛋白质组学分析,以鉴定高危妇女早产开始前的复发早产(rPTB)的生物标志物。方法:2007年至2011年间进行连续CVF抽样的先前自发性早产(PTB)妇女的巢式病例对照研究。使用质谱分析,并进行ELISA分析以验证候选对象。结果:排除了108例患者,并分析了10例和20个胎龄匹配的对照。在748种CVF蛋白中,有72种具有统计学意义(p <0.05)的表达差异,有38种具有高度差异性(p <0.01)。四种候选蛋白丰富并且参与了免疫/炎症反应,但是ELISA分析并未证实表达模式的改变。结论:缺乏通过质谱法和ELISA鉴定的潜在生物标志物的证实,证明了验证PTB生物标志物的挑战,并表明一组生物标志物将提高CVF检测的预测价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号